Focus Partners Wealth’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$497K Sell
25,464
-499
-2% -$9.9K ﹤0.01% 1965
2026
Q1
$499K Buy
25,963
+271
+1% +$5.34K ﹤0.01% 1931
2025
Q4
$487K Buy
25,692
+1,569
+7% +$29.1K ﹤0.01% 1962
2025
Q3
$450K Buy
24,123
+220
+0.9% +$4.11K ﹤0.01% 1655
2025
Q2
$441K Buy
23,903
+757
+3% +$13.4K ﹤0.01% 1506
2025
Q1
$404K Buy
23,146
+2,375
+11% +$40K ﹤0.01% 1437
2024
Q4
$360K Buy
20,771
+797
+4% +$14.6K ﹤0.01% 1469
2024
Q3
$372K Buy
19,974
+14
+0.1% +$236 ﹤0.01% 1254
2024
Q2
$307K Buy
19,960
+845
+4% +$12.1K ﹤0.01% 1067
2024
Q1
$282K Buy
19,115
+5
+0% +$69 ﹤0.01% 852
2023
Q4
$273K Buy
+19,110
New +$271K ﹤0.01% 689

Other funds holding SBRA

Focus Partners Wealth's SBRA Position: Q2 2026 in Review

Focus Partners Wealth reduced its Sabra Healthcare REIT (SBRA) stake by 1.9% in Q2 2026, selling an estimated $9.9K and leaving 25,464 shares worth $497K. The position accounts for ﹤0.01% of the portfolio, ranked #1965.

Focus Partners Wealth first reported a position in SBRA in Q4 2023 and has held it in 11 quarters since. The position peaked at $499K in Q1 2026. 466 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Focus Partners Wealth held 25,464 shares of Sabra Healthcare REIT worth $497K as of Q2 2026.
  • Focus Partners Wealth sold 499 Sabra Healthcare REIT shares in Q2 2026, an estimated $9.9K.
  • Sabra Healthcare REIT made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #1965 holding.
  • Focus Partners Wealth first reported a position in Sabra Healthcare REIT in Q4 2023 and has held it in 11 quarters since.
  • Focus Partners Wealth's Sabra Healthcare REIT position peaked at $499K in Q1 2026.
  • 466 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.